The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 17.13

Mesothelioma

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2011
By Race/Ethnicity, Sex and Years Since Diagnosis
Race/Ethnicity Sex Years Since Diagnosis Completeh
0 to <5 5 to <10 10 to <15 15 to <20 20 to <25 25 to <30 0 to <19e 0 to <36e >=36g
All Races b Both Sexes 3,004 609 314 305 182 129 4,268 4,663 + +
Males 2,172 324 129 83 27 69 2,708 2,829 + +
Females 832 285 185 222 155 60 1,560 1,834 + +
White b Both Sexes 2,767 517 266 268 179 117 3,855 4,210 + +
Males 2,014 278 117 70 24 57 2,479 2,572 + +
Females 753 239 149 198 155 60 1,376 1,638 + +
Black b Both Sexes 167 61 36 24 0 12 289 325 + +
Males 108 38 12 12 0 12 170 195 + +
Females 59 23 24 12 0 0 119 130 + +
Asian/
Pacific
Islander c		 Both Sexes 41 20 7 + + + 70 + + +
Males 23 10 4 + + + 39 + + +
Females 18 10 3 + + + 31 + + +
Hispanic d Both Sexes 216 52 41 + + + 315 + + +
Males 139 34 36 + + + 210 + + +
Females 77 18 5 + + + 105 + + +
Estimated prevalence percent a on January 1, 2011, of the SEERc population diagnosed in the previous 19 years
By Age at Prevalence, Race/Ethnicity and Sex
Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedf
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races c Both Sexes 0.0011% - - - 0.0002% 0.0004% 0.0013% 0.0034% 0.0063% 0.0071% 0.0011%
Males 0.0015% - - - - 0.0004% 0.0015% 0.0047% 0.0097% 0.0140% 0.0017%
Females 0.0008% - - - 0.0004% 0.0004% 0.0012% 0.0023% 0.0035% 0.0030% 0.0007%
White c Both Sexes 0.0014% - - - 0.0002% 0.0005% 0.0015% 0.0040% 0.0074% 0.0075% 0.0013%
Males 0.0018% - - - - 0.0005% 0.0017% 0.0054% 0.0116% 0.0145% 0.0019%
Females 0.0010% - - - 0.0004% 0.0005% 0.0013% 0.0026% 0.0039% 0.0033% 0.0008%
Black c Both Sexes 0.0005% - - - - - 0.0012% - 0.0035% 0.0051% 0.0007%
Males 0.0006% - - - - - - - - - 0.0010%
Females 0.0005% - - - - - - - - - 0.0005%
Asian/
Pacific
Islander c		 Both Sexes 0.0005% - - - - - - 0.0017% 0.0019% 0.0041% 0.0005%
Males 0.0006% - - - - - - 0.0028% - 0.0092% 0.0007%
Females 0.0004% - - - - - - - - - 0.0004%
Hispanic d Both Sexes 0.0006% - - - - - 0.0017% 0.0038% 0.0041% 0.0095% 0.0011%
Males 0.0008% - - - - - 0.0027% 0.0059% 0.0064% 0.0166% 0.0018%
Females 0.0004% - - - - - - 0.0020% - - 0.0006%

Footnotes:

a US 2011 cancer prevalence counts are based on 2011 cancer prevalence proportions from the SEER registries and 1/1/2011 US population estimates based on the average of 2010 and 2011 population estimates from the US Bureau of the Census. Prevalence was calculated using the First Malignant Primary Only for a person.

b Statistics based on SEER 9 Areas.

c Statistics based on SEER 11 Areas and Rural Georgia

d Statistics based on NHIA for Hispanic for SEER 11 Areas and Rural Georgia.

e Maximum limited-duration prevalence: 36 years for 1975-2011 SEER 9 data; 19 years for 1992-2011 SEER 11 data (used to calculate prevalence for Hispanics and Asian Pacific Islanders).

f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

g Cases diagnosed more than 36 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

h Complete prevalence is obtained by summing 0 to <36 and >=36.

i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.